ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1408	National Cancer Institute	Html	en	Grief, Bereavement, and Coping With Loss (PDQ®)–Health Professional Version	Expert-reviewed report about grief, bereavement, and feelings of loss in survivors of someone who has died of cancer. Grief in children is also discussed.	normal grief process 0.581221 unanticipated grief 0.551516 IPT 0.463911 depressive symptoms 0.559773 loss 0.542758 common emotional reactions 0.45155 children 0.526047 interpersonal problems 0.458662 middle phase 0.464448 Health care providers 0.455228 grief counseling exists. 0.565426 grief 0.933904 anticipatory grief 0.744484 health care professionals 0.481565 unanticipated death differs 0.464542 exposure therapy 0.455194 bereaved people 0.453892 grief experiences 0.564377 grief reactions 0.683036 minimal grief reaction—a 0.565 age range 0.479943 grief symptoms 0.544738 deceased person 0.466915 grief intensity 0.535236	necessary grieving process 0.451469 social reactions 0.450213 select grief assessment 0.557139 normal grief 0.697811 death 0.578011 grief bursts 0.548077 IPT group 0.456027 cancer experience 0.45206 grieving process 0.505158 chronic grief reactions 0.566742 complicated grief 0.62885 term anticipatory grief 0.59229 health care 0.509332 common grief reactions 0.572313 pathologic grief reactions 0.569264 normal emotional process 0.454248 bereaved persons 0.498553 severe grief reactions 0.591257 grief disorder 0.543808 actual death 0.478188 grief treatment 0.548186 bereaved persons experience 0.472239 grief experience 0.541082 stage models 0.450278	CLICK HERE
1445	National Cancer Institute	Html	en	Oral Complications of Chemotherapy and Head/Neck Radiation (PDQ®)–Health Professional Version	Expert-reviewed information summary about oral complications, such as mucositis and salivary gland dysfunction, that occur in cancer patients treated with chemotherapy or radiation therapy to the head and neck.	Oral Mucositis section 0.646528 oral lesions 0.713241 permanent oral complications 0.655143 especially oral mucositis 0.68535 hematopoietic stem cell 0.672562 severe oral mucositis 0.704955 normal oral function. 0.655722 oral infection 0.648431 oral anatomic structures 0.655446 cancer therapy 0.661822 oral pain 0.661419 oral tissues 0.687688 oral management 0.671998 oral mucositis 0.976928 acute oral complications 0.672602 oral complications 0.869367 comprehensive oral care 0.65304 cancer patients 0.684573 oral manifestations 0.663979 Poor oral health 0.644837 oral health 0.672192 local oral infections 0.645116 oral mucosal inflammation 0.655414 necessary oral care 0.650666 oral mucositis index 0.679834	severe oral morbidity 0.658041 item oral mucositis 0.6536 oral mucosa 0.692735 oral care 0.722741 oral mucosal changes 0.646052 oral mucositis guidelines 0.662614 radiation-induced oral mucositis 0.65347 oral mucosal tissues 0.663688 Severe oral toxicities 0.662231 ulcerative oral mucositis 0.758526 chemotherapy-induced oral mucositis 0.687692 common oral complications 0.674757 oral mucosal healing 0.660629 comprehensive oral hygiene 0.655656 oral hygiene 0.74644 oral status 0.661747 oral mucosal integrity 0.669711 nonmedicated oral care 0.646962 acute oral GVHD 0.644918 oral mucosal toxicity 0.664745 oral toxicities 0.662473 oral cavity 0.705394 cancer 0.687828 oral disease 0.662382	CLICK HERE
1747	National Cancer Institute	Html	en	Asbestos Exposure and Cancer Risk	A fact sheet about asbestos, asbestos-related diseases, and who to contact for more information.	Asbestos Ombudsman 0.460839 EPA state asbestos 0.434096 U.S. Consumer Product 0.316535 longer exposure time 0.297627 previous exposure 0.27831 asbestos textiles 0.432289 asbestos causes 0.436856 U.S. Department 0.329349 children’s exposure 0.28171 lung cancer 0.280063 asbestos programs 0.405413 asbestos minerals 0.467011 asbestos removal workers 0.468852 Asbestos School Hazard 0.419561 health care providers 0.290173 asbestos-related diseases 0.348349 health hazards 0.295432 human health effects 0.27966 asbestos exposure increase 0.500132 asbestos mines 0.425258 serpentine asbestos 0.481061 asbestos mining 0.432341 Asbestos page 0.442685 Federal agency 0.290215	Environmental Protection Agency 0.377868 OSHA’s Asbestos 0.42031 health effects 0.305637 Preventing Asbestos Exposure 0.47948 Product Safety Commission 0.317357 asbestos 0.915525 asbestos fibers 0.648932 asbestos exposure 0.842565 U.S. Environmental Protection 0.377874 heavier exposure 0.277348 Occupational Safety 0.288197 exposure history 0.275525 asbestos products 0.436695 amphibole asbestos 0.479754 Asbestos Hazard Emergency 0.41964 asbestos-related disease 0.298672 tiny asbestos fibers 0.468171 Health Administration 0.283037 occupational asbestos exposure 0.500171 Consumer Product Safety 0.316531 health 0.344549 Chrysotile asbestos 0.460267 information 0.278169 risk 0.275773	CLICK HERE
1806	National Cancer Institute	Html	es	Tratamiento del cáncer de estómago (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de estómago.	after d2 gastrectomy 0.313513 gastrectomía d2 0.31496 Cunningham D 0.34388 Macdonald JS 0.318723 Chemoradiotherapy after surgery 0.344328 randomised controlled 0.319618 combined modality therapy 0.360634 mejoría significativa 0.31176 Stenning SP 0.310838 intergroup trial calgb 0.31542 Postoperative adjuvant chemoradiation 0.322032 after ci 5-fu 0.317294 fase iii 0.364462 Estados Unidos 0.347269 with s-1 0.314235 randomized trial comparing 0.314288 quimiorradioterapia posoperatoria 0.360835 ensayo rtog-9904 0.324678 patients with 0.484752 adyuvante versus tasa 0.360686 supportive care 0.325372 Clinical Oncology 0.311085 Perioperative chemotherapy versus 0.334581 chemotherapy plus best 0.312401 Smalley SR 0.318682	with surgery 0.339493 Ajani JA 0.354002 or gastroesophageal junction 0.340588 ensayo swog-s0425 0.324881 Allum WH 0.311046 quimiorradioterapia adyuvante versus 0.364135 estadio ib 0.338006 gastrectomía curativa d2 0.319296 Van Cutsem E 0.313883 Benedetti J 0.318647 quimioterapia perioperatoria 0.352185 gastric carcinoma 0.325701 gastric cancer 0.935626 Clin Oncol 0.612714 or gastro-oesophageal junction 0.317111 trial comparing 0.314461 supportive care with 0.324232 Winter K 0.319459 Gastric Cancer Study 0.317632 chemotherapy versus surgery 0.338116 grupo s-1 0.317965 Okawara GS 0.319919 care with best 0.314996 quimioterapia posoperatoria 0.31518	CLICK HERE
1871	National Cancer Institute	Html	es	Tratamiento del carcinoma de sitio primario desconocido (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del carcinoma de sitio primario desconocido.	cáncer epitelial versus 0.404134 Greco FA 0.432795 unknown primary tumours 0.414817 cisplatin-based combination chemotherapy 0.404363 unknown primary site 0.721557 Pavlidis N 0.405224 Breast carcinoma presenting 0.411406 unknown primary origin 0.450607 Hainsworth JD 0.442528 Metastatic malignant melanoma 0.405856 Cancer Res 0.404192 Radiat Oncol Biol 0.414855 neuroendocrine carcinoma 0.415368 Natl Cancer Inst 0.417117 poorly differentiated 0.438667 Melanoma from unknown 0.410685 serous papillary carcinoma 0.405287 patients with 0.456873 gene expression profiling 0.404698 unknown primary carcinoma 0.451216 carcinoma nasofaríngeo 0.409399 poorly differentiated carcinoma 0.41977 cervical lymph 0.404293 patients with unknown 0.4336 Rodriguez E 0.405003	presenting as axillary 0.404521 metastases from unknown 0.428245 Unknown primary melanoma 0.416245 Abbruzzese MC 0.404845 Curr Probl Cancer 0.404442 primary neoplasm 0.406005 or undiscovered primary 0.406863 from unknown primary 0.455678 primary tumor site 0.417993 Surg Oncol 0.405079 PDQ Tratamiento 0.416061 Intern Med 0.413673 nasopharyngeal carcinoma 0.405469 Clin Oncol 0.44391 Johnson DH 0.404766 unknown primary 0.993061 Oncol Biol Phys 0.415244 with unknown primary 0.46599 metastatic adenocarcinomas 0.408539 unknown primary tumor 0.442645 germ cell tumors 0.405207 carcinoma presenting as 0.411228 occult primary carcinoma 0.410287 cancer incidence 0.406991	CLICK HERE
1943	National Cancer Institute	Html	es	Síndromes cardiopulmonares (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las afecciones comunes que producen síntomas en el tórax. Los síndromes cardiopulmonares que se exponen en este sumario son la disnea relacionada con el cáncer, el derrame pleural maligno, el derrame pericárdico y el síndrome de la vena cava superior.	pleural catheter 0.17861 Ripamonti C 0.130559 dificultad respiratoria 0.26023 malignant effusion 0.115362 lung cancer 0.190962 Sin embargo 0.114284 end-of-life patients with 0.119385 indwelling pleural catheter 0.162022 Dudgeon DJ 0.13043 fármacos pleurales esclerosantes 0.112004 disfunción muscular respiratoria 0.121219 Hematol Oncol Clin 0.143013 hypoxemic patients with 0.118489 patients receiving chemotherapy 0.111162 Cancer Organisation Thoracic 0.117844 antitusivos opioides 0.112496 recurrent symptomatic malignant 0.110714 patients with 0.625852 insuficiencia cardiaca 0.134239 Pain Symptom Manage 0.478956 randomized controlled 0.112081 pleural fluid 0.136904 Cancer Dyspnea Scale 0.146703 Moroni M 0.110841 Care Cancer 0.128094	pleural catheter vs 0.135869 Physiol Neurobiol 0.116436 as symptomatic treatment 0.110943 derrame maligno fracasa 0.114534 obstructiva crónica 0.135859 vías respiratorias 0.205286 tunnelled pleural catheter 0.139919 tos crónica causa 0.111919 prospective randomized 0.110614 pleural effusions with 0.149859 Intern Med 0.132242 Clin Oncol 0.11762 Med Pediatr Oncol 0.111608 Clin North Am 0.136363 Bruera E 0.203018 systematic review 0.116364 Oncol Clin North 0.140711 American Thoracic Society 0.114142 as palliative treatment 0.110799 malignant pleural effusions 0.900896 Crit Care Med 0.171232 symptomatic malignant 0.122652 alone versus 0.11566 compared with 0.110951	CLICK HERE
2063	National Cancer Institute	Html	es	Radón y cáncer	Hoja informativa acerca del radón, un gas radiactivo sin olor, y su posible asociación con el cáncer, y cómo realizar pruebas de detección del radón en el hogar.	residential radon case-control 0.38371 Health Risks 0.326257 residential radon 0.683536 elevada exposición 0.322129 American case-control studies 0.325499 Kansas State University 0.319808 lung cancer 0.82038 largo plazo 0.437964 Hill D 0.332319 Scandinavian Journal 0.348044 persons with lung 0.339213 Danish study 0.316865 Environmental Epidemiology 0.320216 Darby S 0.336246 collaborative analysis 0.317051 Environmental Health 0.355768 pequeñas partículas 0.315096 mundo inhala radón 0.518177 Lubin JH 0.346614 combined analysis 0.316876 Estados Unidos 0.584661 likely carcinogen 0.314203 Family From Radon 0.368415 elementos químicos uranio 0.332786 PubMed Abstract 0.939015	Field RW 0.336674 altas concentraciones 0.370467 Cancer Journal 0.333846 Environmental Protection Agency 0.326738 National Radon Hotline 0.369701 Health Effects 0.325858 radón causa 0.50069 Public Health 0.325273 concentración promedio 0.346248 epidemiologic studies 0.342525 disponibles pruebas 0.317342 Exposure Analysis 0.331287 Health Physics 0.355359 BEIR VI 0.314333 gas radón 0.662121 Protecting Yourself 0.31429 corto plazo 0.315556 Residential radon gas 0.389098 risk among german 0.327785 persons without lung 0.339772 única forma 0.341742 Samet JM 0.31548 Retrieved October 0.315338 Zielinski JM 0.315284	CLICK HERE
2082	National Cancer Institute	Html	en	Cancer Clusters	A fact sheet that describes what constitutes a cancer cluster and the process for reporting and investigating suspected clusters.	major risk factor 0.385962 specific environmental hazards 0.38074 rare cancer 0.409989 website uses data 0.380594 cancer trends 0.398646 individual cancer clusters 0.469731 number 0.405815 investigators 0.393508 Health Hazard Evaluation 0.380995 Disease Control 0.519415 Health Consultations page 0.381331 cancer cluster 0.895701 cancer clusters 0.841764 National Center 0.381056 ATSDR regional offices 0.380684 different geographic area 0.38274 cluster investigations 0.411002 true cancer clusters 0.482566 public health assessments 0.472612 statistically significant difference 0.384068 vinyl chloride 0.380035 specific cancer type 0.434002 primary cancer 0.413707 U.S. Census Bureau 0.37492 specific hazardous substances 0.37613	different cancer types 0.429181 state health department 0.450442 total number 0.385248 cancer cases 0.749447 health departments 0.457783 NCI analyze variations 0.380726 local health departments 0.450682 geographic area 0.518161 specific geographic area 0.389344 health surveillance programs 0.382617 people 0.378106 epidemiologic study 0.378396 agency gathers information 0.381997 statistically significant excess 0.455543 secondary cancer 0.393665 cancer 0.954313 state cancer registries 0.443891 cancer cluster—that 0.391887 Disease Registry 0.381886 specific time period 0.392616 Toxic Substances 0.380998 cancer death rates 0.436653 cancer incidence 0.401099 Cancer Mortality Maps 0.435229	CLICK HERE
3597	National Cancer Institute	Html	en	MERIT Award Recipient: Laimonis A. Laimins, Ph.D.	MERIT Award Recipient: Laimonis A. Laimins, Ph.D.	productive life cycle 0.692492 anti-viral therapies 0.414992 long-term objective 0.415026 viral particles 0.475434 viral factor 0.465899 HPV types 0.533205 Viral infection 0.48447 HPV proteins functions 0.60071 proliferative lesions 0.427068 stratified epithelial cells 0.554619 E4 protein 0.416206 small DNA viruses 0.509754 development 0.367942 life cycle 0.732336 tissue culture 0.408683 cervical cancer 0.697893 anogenital cancers 0.416749 viral replication 0.470226 pathogenesis 0.323941 certain types 0.427907 late viral functions 0.551387 HPV functions 0.507234 genetic analyses 0.407346 HPV infections 0.62415 activation 0.321394	productive viral life 0.570807 blocks infection 0.430045 E5 protein 0.409072 differentiation 0.394198 HPVs 0.330868 methods 0.33537 virion assembly 0.42345 genome amplification 0.41342 human papillomaviruses 0.908593 Oncogenic Papillomaviruses 0.574563 organotypic cultures 0.4081 normal cells 0.43284 suprabasal cells 0.432461 cases 0.370169 effective anti-virals 0.431518 epithelial cells 0.561264 protein synthesis 0.412779 HPV viral proteins 0.658868 vaccine 0.388142 Additional studies 0.403147 future 0.32145 cell death pathway 0.503149 high-risk types 0.424894 grant 0.339966	CLICK HERE
16812	National Cancer Institute	Html	es	Cartílago (bovino y de tiburón) (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de cartílago bovino y de tiburón como tratamiento para personas con cáncer. Nota: la información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	MIA Shark Powder 0.309592 libera productos 0.304775 Centro Nacional 0.308058 New Hampshire Avenue 0.30568 Drug Administration 0.303513 NCI Best Case 0.309322 vía oral 0.453913 datos bibliográficos pubmed 0.30595 células llamadas condrocitos 0.314707 siguientes preguntas 0.30389 numerosos productos 0.303672 cartílago bovino catrix 0.352078 National Cancer Institute 0.306865 siguientes riesgos 0.304822 Instituto Nacional 0.331095 Salud Complementaria 0.311787 Visuals Online 0.304093 complementarias revisa 0.305499	Physician Data Query 0.323561 Estados Unidos 0.439543 PDQ Cartílago 0.345303 siguientes estudios 0.31921 libre uso 0.304173 cartílago bovino 0.858349 página manejo 0.303836 tiburón quizás 0.3125 numerosos estudios 0.308556 ¿El tratamiento 0.308146 tiburón llamada ae-941 0.314557 siguientes datos 0.30538 ¿Los beneficios 0.303518 juntos cam 0.30337 Series Program 0.303472 vasos sanguíneos 0.95448 medicina complementaria 0.461353	CLICK HERE